【关键词】 长效人胰高糖素样肽-1类似物 肥胖 初诊 糖尿病，2型 胰岛功能
Improvement of pancreatic islet function of one obese patient treated by long-acting human GLP-1 analogue Liraglutide singly JIANG Lin, YANG Tao. Department of Endocrinology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029
Corresponding author: YANG Tao, E-mail: firstname.lastname@example.org
【Summary】 In this report, one case of obese patient, newly diagnosed T2DM, was treated with long-acting human glucagon like peptide-1 (GLP-1) analogue Liraglutide singly for three months. In addition to his glycemic control, an improvement in his blood pressure and blood lipid and weight loss was achieved after treatment. What is more that his pancreatic islet function and insulin sensitivity were also changed better. There was no hypoglycemia and other obvious adverse reactions observed during the treatment. This therapeutic scheme provided a new target for newly diagnosed T2DM patients. Liraglutide is expected to become an ideal drug for early treatment of such patients.
【Key words】 Long-acting human glucagon like peptide-1 (GLP-1) analogue; Obese; Liraglutide; Newly diagnosed T2DM patient; Islet
版权所有:《中国糖尿病杂志》社 主管单位：中华人民共和国教育部 主办单位：北京大学
地址：北京市西城区大红罗厂街1号 邮编：100034 电话（传真）：010-88505683
中国糖尿病杂志社版权所 京ICP备11029051号-1 Powered by JiuduCMS 技术支持：九度创想